The percentage of CD4+/PD-L1+ T cells was also significantly higher in the CHD-PAH group (p < 0.001) and CTEPH group (p < 0.001) than in the control group. The gene discussed is CD274; the disease is chronic thromboembolic pulmonary hypertension.